Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence

Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence

IntroductionLong COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC) in ∼30% of all infected individuals. Here, we present a case of PASC in a patient with rheumatoid arthritis characterized by viral persistence in the nasopharynx for 6 months after acute infection. We demonstrate transient...

Full description

Bibliographic Details
Main Authors: Lavanya Visvabharathy, Zachary S. Orban, Igor J. Koralnik
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Medicine
Subjects:
long COVID
nirmatrelvir/ritonavir
tocilizumab
autoimmunity
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.1003103/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.1003103/full

Similar Items